AGP Picks
View all

AGP Executive Report

Last update: 7 hours ago

Cannabis & Mental Health: A new India-based study comparing new-onset psychosis tied to confirmed cannabis exposure vs non-cannabis psychosis found better cognitive gains and symptom improvements after 4 weeks of inpatient treatment in the cannabis-associated psychosis group. Sleep & Consumer Claims: An AASM survey reports 64% of cannabis consumers say it helps them sleep, while also flagging risks like daytime sleepiness and impaired driving. Policy & Market Pressure: The National Restaurant Association is urging Congress to delay a ban on hemp-derived THC drinks, asking for a clear federal regulatory framework (age checks, labeling, dosing, impairment standards). Industry Scrutiny: A Lancet Psychiatry study argues that removing criminal penalties doesn’t necessarily raise overall cannabis use, but commercial markets may drive more potent products and higher addiction risk. Product/Ad Reality Check: A CBD outreach piece warns brands face near-total ad blackouts on Google, Meta, and TikTok, pushing “guest posts” that can trigger penalties if they look like paid link schemes. Safety/Enforcement: A drug-affected driver in Australia was fined and disqualified after mounting a roundabout and crashing; cannabis was found in his system. Access Gap: A Cook Islands letter says medicinal cannabis laws still leave residents unable to fill prescriptions locally, forcing repeated travel abroad.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
2 hours ago

Kentucky patients must buy medical cannabis in-state starting July 1

AGP

fallback image
Jun. 17, 2026

DRM launches Core 7 collaboration for commercial cannabis operators

AGP

fallback image
Jun. 17, 2026

Patient coalition appeals Czech CBD restriction plan

AGP

fallback image
Jun. 17, 2026

NeuroKaire report finds depressed Americans self-treat with cannabis, screens and weight-loss drugs

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Opinion: A common-sense fix for New Hampshire’s Therapeutic Cannabis Program

Opinion: A common-sense fix for New Hampshire’s Therapeutic Cannabis Program

Allowing the commercialisation of cannabis could contribute to problematic use

Allowing the commercialisation of cannabis could contribute to problematic use

Supreme court sides with Texas marijuana user who wants to own a firearm in latest case expanding gun rights – live

Supreme court sides with Texas marijuana user who wants to own a firearm in latest case expanding gun rights – live

Could Tennessee reopen the medical marijuana debate? Here’s why

Could Tennessee reopen the medical marijuana debate? Here’s why

More seniors are using cannabis. Utah and Colorado researchers want to know why

More seniors are using cannabis. Utah and Colorado researchers want to know why


fallback image
2 hours ago

Governor Beshear Rescinds Out-of-State Medical Cannabis Order: Local Access Now Required at Kentucky Dispensaries

EIN Presswire

fallback image
Jun. 17, 2026

Patient coalition launches appeal over plan to restrict CBD: 'Care before discrimination'

EIN Presswire

fallback image
Jun. 17, 2026

1 in 5 Depressed Americans Are Self-Medicating With Screens, Cannabis, Weight-Loss Drugs & More, New Report Finds

EIN Presswire

fallback image
Jun. 16, 2026

Leafwell Publishes New PTSD Study, Builds on Evidence Supporting Medical Cannabis for Chronic Pain, Complex Chronic Conditions and Healthcare Affordability

GlobeNewswire, Inc.

fallback image
Jun. 16, 2026

GreenSpace Labs Reports Positive Phase 2 Pilot Data for CBD-Based IBS Therapy GSL-01-001

EIN Presswire

fallback image
Jun. 15, 2026

Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Proposed Jeffersonville Cannabis Dispensary Location Causing Controversy
Play
Proposed Jeffersonville Cannabis Dispensary Location Causing Controversy
YouTube video thumbnail: Sacramento Leaders Approve new Cannabis Dispensary Zones
Play
Sacramento Leaders Approve new Cannabis Dispensary Zones
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How Virginia's Recreational Marijuana Plan Could Impact Hemp Farmers
Play
How Virginia's Recreational Marijuana Plan Could Impact Hemp Farmers
YouTube video thumbnail: New York Times Admits US Has Marijuana Problem, Urges Regulation
Play
New York Times Admits US Has Marijuana Problem, Urges Regulation

Video Title

Sign up for:

Medical Bud News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Bud News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.